10-Q: Healthcare AI Acquisition Corp. Faces Delisting, Liquidity Concerns

Healthcare AI Acquisition Corp. reports significant net losses, dwindling trust account funds due to high redemptions, and delisting from Nasdaq, raising substantial doubt about its ability to continue as a going concern.

Summary

• Reported a net loss of $542,059 for the three months ended June 30, 2025, and a net loss of $616,178 for the six months ended June 30, 2025.
• Cash and investments held in the trust account decreased from $4,664,536 as of December 31, 2024, to $1,865,847 as of June 30, 2025, primarily due to significant share redemptions.
• The working capital deficit increased from $2,271,434 as of December 31, 2024, to $2,503,403 as of June 30, 2025.
• Warrant liability significantly increased from $122,675 as of December 31, 2024, to $657,185 as of June 30, 2025.
• Promissory notes from related parties increased to $907,028 as of June 30, 2025, from $675,751 as of December 31, 2024.
• The company was delisted from Nasdaq on December 17, 2024, and its securities now trade on OTC Markets Group, Inc. Pink Open Market.
• An agreement for a Business Combination with Leading Group Limited, a digital insurance brokerage, was entered into on August 15, 2024.
• Shareholders approved multiple extensions for the business combination deadline, most recently to October 14, 2026.
• Management identified material weaknesses in disclosure controls and internal control over financial reporting related to complex financial instruments and recording of payables.

Sentiment

Score: 2

Explanation: The company faces severe financial distress, including significant net losses, dwindling cash in its trust account due to high redemptions, and a substantial working capital deficit. The delisting from Nasdaq and ongoing reliance on related-party loans for extensions highlight extreme operational and financial challenges, raising substantial doubt about its ability to continue as a going concern.

Positives

• Successfully entered into a Business Combination Agreement with Leading Group Limited on August 15, 2024.
• Shareholders approved multiple extensions for the business combination deadline, providing additional time until October 14, 2026.
• Underwriters waived their entitlement to $7,546,840 in deferred underwriting discount, reducing a significant potential liability.

Negatives

• Reported a net loss of $542,059 for the three months ended June 30, 2025, and $616,178 for the six months ended June 30, 2025, compared to a net income of $145,656 and a net loss of $321,060 for the corresponding periods in 2024.
• Cash and investments in the trust account significantly decreased from $4,664,536 to $1,865,847, primarily due to $2,948,990 in redemptions during the six months ended June 30, 2025.
• The working capital deficit increased to $2,503,403 as of June 30, 2025, from $2,271,434 as of December 31, 2024.
• Warrant liability increased substantially from $122,675 as of December 31, 2024, to $657,185 as of June 30, 2025.
• Delisted from Nasdaq on December 17, 2024, and now trades on OTC Markets, leading to reduced liquidity and market quotations for its securities.
• Management concluded that disclosure controls and procedures were not effective due to material weaknesses in analyzing complex financial instruments and recording of accounts payable and accrued expenses.
• The company is considered a 'penny stock' under Rule 419, which imposes burdensome trading rules and may reduce trading activity.
• Management has determined that mandatory liquidation and dissolution, if a business combination is not completed, raises substantial doubt about the company's ability to continue as a going concern.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern due to insufficient liquidity and the uncertainty of completing a business combination.
• Failure to complete the Business Combination with Leading Group Limited by October 14, 2026, will result in mandatory liquidation and dissolution.
• Delisting from Nasdaq adversely affects the liquidity and trading of its securities, potentially impacting the ability to complete the Business Combination.
• Being deemed a 'penny stock' under Rule 419 imposes stringent trading rules on brokers, which may reduce trading activity and make it more difficult for holders to sell shares.
• The company may be considered an unregistered investment company, which could force it to abandon its business combination efforts and liquidate.
• Changes in laws or regulations, particularly proposed SEC rules for SPACs, could materially increase the costs and time required to complete an initial business combination.
• Geopolitical instability from ongoing conflicts (Russia-Ukraine, Israel-Hamas) could lead to market disruptions, volatility, and supply chain interruptions.
• The Business Combination may be subject to U.S. foreign investment regulations and review by CFIUS, potentially delaying or prohibiting the transaction.
• The post-Business Combination combined company may face challenges meeting Nasdaq listing requirements, such as minimum bid price and market value of publicly held shares.

Future Outlook

The company anticipates that its current cash outside the Trust Account is insufficient to sustain operations for the next 12 months without completing a business combination. There is significant uncertainty regarding the consummation of the business combination with Leading Group Limited by the extended deadline of October 14, 2026. If the business combination is not completed, the company faces mandatory liquidation and dissolution. The combined company, Leading Partners Limited, intends to apply for listing its ordinary shares and warrants on Nasdaq under symbols LDIN and LDINW upon the completion of the Business Combination.

Management Comments

• "Management has determined that mandatory liquidation, and subsequent dissolution, should the Company be unable to complete a business combination, raises substantial doubt about the Company’s ability to continue as a going concern for the next twelve months from the issuance of these financial statements."
• "The Company anticipates that the cash held outside of the Trust Account as of June 30, 2025 might not be sufficient to allow the Company to operate for at least the next 12 months from the issuance of the financial statements, assuming that a business combination is not consummated during that time."
• "Based on this evaluation, our principal executive officer and principal financial officer have concluded that during the period covered by this Quarterly Report, our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were not effective due to material weaknesses in analyzing complex financial instruments, specifically the valuation of warrant liabilities, and recording of accounts payable and accrued expenses."

Industry Context

Healthcare AI Acquisition Corp. operates as a Special Purpose Acquisition Company (SPAC) attempting to complete a de-SPAC transaction with Leading Group Limited, a digital insurance brokerage based in the People's Republic of China. The broader SPAC market has experienced increased regulatory scrutiny, higher redemption rates, and challenges in completing business combinations, as evidenced by HAIA's delisting from Nasdaq. Cross-border transactions, especially those involving Chinese entities, are subject to additional complexities, including U.S. foreign investment regulations like CFIUS review, which can prolong or even prohibit deals. The company's struggles reflect a challenging environment for SPACs, particularly those facing extended timelines and significant investor redemptions.

Comparison to Industry Standards

• The company's high redemption rates (e.g., 19,824,274 shares for $10.54/share, 1,146,276 shares for $10.73/share, 192,664 shares for $11.60/share, 246,676 shares for $11.95/share) are significantly above historical SPAC averages, indicating a severe lack of investor confidence in the proposed business combination or the SPAC's viability.
• The delisting from Nasdaq and subsequent trading on OTC Markets is a critical failure to meet standard SPAC listing expectations, contrasting sharply with successful SPACs that maintain major exchange listings for the combined entity.
• The continuous need for extensions and reliance on related-party promissory notes and working capital loans to fund operations and trust account deposits is characteristic of a distressed SPAC, diverging from well-performing SPACs that typically complete combinations within initial timelines and with sufficient independent capital.

Management Changes

Corporate Governance

Related Party Transactions

• Promissory notes from the New Sponsor, New Sponsor's shareholder, and LEADING for working capital and extension payments, totaling $907,028 as of June 30, 2025.
• Working Capital Loans from the New Sponsor totaling $447,174 as of June 30, 2025.
• The Former Sponsor waived entitlement to $177,095 in administrative service fees and transferred $347,285 in deferred legal expenses as capital contributions.
• The New Sponsor does not charge administrative service fees to the company.

Stakeholder Impact

• Shareholders face significant risk of investment loss due to high redemptions, potential for warrants to expire worthless, reduced liquidity and market value from Nasdaq delisting and 'penny stock' status, and the ultimate risk of mandatory liquidation.
• The New Sponsor and other related parties are bearing substantial financial risk by providing ongoing loans to fund extensions and working capital, indicating a deep commitment to the business combination.
• The target company, Leading Group Limited, faces prolonged uncertainty and potential delays in its strategic plans due to the SPAC's ongoing challenges in completing the business combination.
• Underwriters have waived $7,546,840 in deferred underwriting commissions, representing a loss of potential revenue for them.

Next Steps

• Complete the Business Combination with Leading Group Limited by the extended deadline of October 14, 2026.
• Leading Partners Limited (Holdco) will apply to list its ordinary shares and warrants on Nasdaq under symbols LDIN and LDINW upon the completion of the Business Combination.
• Address the identified material weaknesses in internal control over financial reporting.

Key Dates

Recommendation

The company is in a highly precarious financial position, marked by substantial net losses, a rapidly depleting trust account due to massive redemptions, and a significant working capital deficit. Its delisting from Nasdaq to OTC Markets, coupled with 'penny stock' status, severely impairs liquidity and market attractiveness. The repeated extensions for the business combination, funded by related-party loans, underscore the difficulty in closing the deal. Management's acknowledgment of material weaknesses in internal controls further erodes confidence. The substantial doubt about its ability to continue as a going concern, combined with the risk of mandatory liquidation, makes this a high-risk investment with a strong likelihood of further capital erosion.

Keywords

SPAC, Healthcare AI, Leading Group Limited, Business Combination, Delisting, Nasdaq, OTC Markets, Warrant Liability, Going Concern, Redemption, Promissory Note, Financial Services, Digital Insurance Brokerage, Cayman Islands